Private Equity
Organic Motion, a New York-based provider of computer vision and motion capture systems, has raised $7.4 million in Series B funding led by Foundry Group.
2 min read · 22 October 2009
2 min read · 22 October 2009
HealthGuru Media, a New York-based health website for 18-40 year-olds, has raised $3.2 million in Series C funding. Castile Ventures led the round, and was joined by return backer Village Ventures.
3 min read · 21 October 2009
Chango, a Toronto-based online advertising solution, has raised C$750,000 in Series A funding. iNovia Capital led the round, and was joined by Extreme Venture Partners.
2 min read · 21 October 2009
GlycoMimetics, a Gaithersburg, Md.-based developer of glycobiology-based therapies, has raised $38 million in third-round funding. Genzyme Ventures was joined by return backers New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures. The company previously raised around $25 million.
3 min read · 21 October 2009
RiseSmart, a San Jose, Calif.-based provider of online outplacement and job search services, has raised $4.6 million in new Series A funding. Storm Ventures led the round, and was joined by Norwest Venture Partners. The company previously raised $4.25 million from Norwest and individual angels.
3 min read · 21 October 2009
Copanion Inc., an Andover-based provider of, has raised $10.2 million in Series B funding co-led by return backers Commonwealth Capital Ventures and Pilot House Ventures. The company previously raised $9 million.
2 min read · 21 October 2009
Synageva BioPharma Corp., a Waltham, Mass.-based developer of protein therapeutics, has raised $12 million in new six-thround funding, bringing the round total to $45 million. New Leaf Venture Partners joined existing backers Hunt BioVentures, Yasuda Enterprise Development, Baker Brothers Investments, Tullis Dickerson and Four Partners. The company has now raised around $95 million.
4 min read · 21 October 2009
Vertos Medical Inc., an Aliso Viejo, Calif.-based developer of minimally-invasive devices for lumbar spine decompression, has raised $15.5 million in Series D funding. Onset Ventures led the round, and was joined by return backers CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury. The company previously raised around $17 million.
3 min read · 21 October 2009
Tarsa Therapeutics Inc. has raised $24 million in Series A funding. MVM Life Science Partners led the round, and was joined by Quaker BioVentures and Novo AS. In related news, Unigene Laboratories Inc. (OTCBB: UGNE) has licensed its Phase III oral calcitonin program to Tarsa, in exchange for a 25% ownership position.
5 min read · 21 October 2009
